Physicians' Academy for Cardiovascular Education

LDL-c targets in the ESC/EAS dyslipidaemia guidelines in a nutshell

10' education - Oct. 4, 2019 - Prof. Brian Ference, MD - Cambridge, UK

Video navigation menu

  • Foundation of the new guidelines 0:27
  • Recommendations for CVD risk estimation 2:14
  • Recommendations for treatment goals for LDL-c 6:11

Educational information

This lecture by prof. Brian Ference was part of an accredited symposium "LDL-c guidance on the novel ESC/EAS dyslipidaemia guidelines: Expert discussions on practical implications" held during ESC 2019 in Paris, France.

Faculty

Prof. Brian A. Ference, M.D, Professor and Director of Research in Translational Therapeutics, Executive Director, Centre for Naturally Randomized Trials, University of Cambridge, United Kingdom

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Amgen, Sanofi-Regeneron and Pfizer - Upjohn.

Read our summary of the ESC/EAS Dyslipidemia Guidelines View the slides of this presentation

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: